Assessment of compliance and relapse in patients with schizophrenia before and after the onset of COVID-19 pandemic.

Bassiony, Medhat M; Sehlo, Mohammad G; Ibrahim, Eman F; Zayed, Alaa E; Atwa, Samar A

Bassiony, Medhat M; Sehlo, Mohammad G; Ibrahim, Eman F; Zayed, Alaa E; Atwa, Samar A.

Afiliación

Bassiony MM; Department of Psychiatry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Sehlo MG; Department of Psychiatry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Ibrahim EF; Department of Psychiatry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Zayed AE; Department of Psychiatry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Atwa SA; Department of Psychiatry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Int J Psychiatry Clin Pract ; 27(2): 127-133, 2023 Jun.

Article en En | MEDLINE | ID: mdl-36149774

Asunto(s)

Antipsicóticos; COVID-19; Esquizofrenia; Adulto; Humanos; Esquizofrenia/epidemiología; Esquizofrenia/terapia; Pandemias; Antipsicóticos/efectos adversos; Estudios Retrospectivos; Recurrencia; Escalas de Valoración Psiquiátrica

Palabras clave

COVID-19; Egypt; Schizophrenia; compliance; relapse

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Int J Psychiatry Clin Pract Año: 2023 Tipo del documento: Article País de afiliación: Egipto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google